Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds

NCT02602184 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Wounds and Injuries

Interventions

DRUG: AR/101
DRUG: Placebo

Sponsor

Arava Bio Tech Ltd.

Collaborators

[object Object]